Article Figures & Data
Figures
- Figure 1
- Receiver-operating characteristic curve of neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) for predicting patients with lung involvement of coronavirus disease -19 (COVID-19) in in the study population. AUC: area under the curve, CI: confidence interval
Tables
- Table 1
- The baseline imaging characteristics of the COVID-19 patients with CT findings (n=131).
Characteristics n (%) Left upper lobe 53 (40.5) Left lower lobe 108 (82.4) Right upper lobe 74 (56.5) Right middle lobe 64 (48.9) Right lower lobe 101 (77.1) Ground glass opasities 125 (95.4) Consolidation 65 (49.6) Reticular pattern 78 (59.5) Crazy paving pattern 45 (34.4) Lymphadenopathy 12 (9.2) Pleural efussion 5 (3.8) Total lung severity score, median (min-max) 6.9 (1-18) COVID-19: Coronavirus disease -19, CT: computed tomography
- Table 2
- Comparison of laboratory features of COVID-19 patients with and without CT findings.
Variables COVID-19 patients P-value With CT findings (n=131) Without CT findings (n=84) Mean±SD Age, years 48.3±15.6 38.9±15.0 <0.0001 Gender, n (%) Male 58 (44.3) 44 (52.4) 0.247 Female 73 (55.7) 40 (47.6) Hemoglobin, g/dL 14.06±1.80 14.45±1.78 0.033 INR 1.08±0.17 1.07±0.10 0.754 CRP, mg/L, median (min-max) 7.95 (0.60-552.33) 3.36 (0.60-40.60) 0.010 Ferritin, median (min-max) 89.30 (9.60-851) 85.10 (7.80-776.50) 0.140 D-dimer, ng/mL, median (min-max) 127 (18-3524) 90 (7-2164) 0.355 Platelet, ×109/L 218.97±63.61 221±58.28 0.811 Leucocyte, ×109/L 5.97±2.41 5.77±1.87 0.508 Neutrophil, ×109/L 3.94±2.41 3.44±1.67 0.079 Lymphocyte, ×109/L 1.52±0.70 1.71±0.59 0.033 NLR, median (min-max) 2.22 (0.63-25.57) 1.88 (0.53-8.61) 0.001 PLR, median (min-max) 142.77 (57.94-495.83) 130.65 (39.39-325.74) 0.005 COVID-19: coronavirus disease -19, CT: computed tomography, INR: international normalized ratio, CRP: C-reactive protein, NLR: neutrophil to lymphocyte ratio, PLR: platelet to lymphocyte ratio, SD: standard deviation
- Table 3
- The correlation between CRP, ferritin and the other markers according to TLSS in patients with COVID-19.
TLSS r P-value Hemoglobin, g/dL 0.153 0.081 CRP, mg/L 0.599 <0.0001 Ferritin 0.328 0.008 Platelet, ×109/L -0.174 0.047 Leucocyte, ×109/L -0.103 0.241 Neutrophil, ×109/L 0.027 0.756 Lymphocyte, ×109/L -0.329 <0.0001 D-dimer, ng/mL 0.285 0.013 NLR 0.225 0.010 PLR 0.244 0.005 CRP: C-reactive protein, COVID-19: coronavirus disease -19, TLSS: total lung severity score, NLR: neutrophil to lymphcyte ratio, PLR: platelet to lymphocyte ratio
- Table 4
- Linear regression analysis for TLSS in patients with coronavirus disease -19 (COVID-19).
Independent variables Beta regression coefficient P-value BUN -0.058 0.300 Creatinine 0.044 0.552 ALT -0190 0.243 AST 0.395 0.073 LDH 0.895 0.035 INR 0.182 0.151 CRP 1.839 0.019 Ferritin -1.738 0.019 Platelet -2.999 0.041 Leucocyte -0.841 0.454 Neutrophil 4.077 0.084 Lymphocyte -0.380 0.379 NLR 4.370 0.036 PLR -4.161 0.024 TLSS: total lung severity score, BUN: blood urea nitrogen, ALT: alanine transaminase, AST: aspartate transaminase, LDH: lactate dehydrogenase, INR: international normalized ratio, CRP: C-reactive protein, NLR: neutrophil to lymphocyte ratio, PLR: platelet to lymphocyte ratio
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.